Médica Sur S.A.B. de C.V (MEDICAB) - Net Assets
Based on the latest financial reports, Médica Sur S.A.B. de C.V (MEDICAB) has net assets worth MX$2.52 Billion MXN (≈ $145.18 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (MX$4.78 Billion ≈ $274.90 Million USD) and total liabilities (MX$2.25 Billion ≈ $129.72 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of Médica Sur S.A.B. de C.V to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | MX$2.52 Billion |
| % of Total Assets | 52.81% |
| Annual Growth Rate | 6.75% |
| 5-Year Change | -48.67% |
| 10-Year Change | -23.73% |
| Growth Volatility | 14.26 |
Médica Sur S.A.B. de C.V - Net Assets Trend (2000–2025)
This chart illustrates how Médica Sur S.A.B. de C.V's net assets have evolved over time, based on quarterly financial data. See Médica Sur S.A.B. de C.V liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Médica Sur S.A.B. de C.V (2000–2025)
The table below shows the annual net assets of Médica Sur S.A.B. de C.V from 2000 to 2025. For live valuation and market cap data, see market value of Médica Sur S.A.B. de C.V.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | MX$2.52 Billion ≈ $145.18 Million |
+7.62% |
| 2024-12-31 | MX$2.34 Billion ≈ $134.90 Million |
+15.06% |
| 2023-12-31 | MX$2.04 Billion ≈ $117.24 Million |
-19.23% |
| 2022-12-31 | MX$2.52 Billion ≈ $145.16 Million |
-48.67% |
| 2021-12-31 | MX$4.91 Billion ≈ $282.82 Million |
+22.59% |
| 2020-12-31 | MX$4.01 Billion ≈ $230.71 Million |
+8.86% |
| 2019-12-31 | MX$3.68 Billion ≈ $211.93 Million |
+3.97% |
| 2018-12-31 | MX$3.54 Billion ≈ $203.83 Million |
+2.75% |
| 2017-12-31 | MX$3.45 Billion ≈ $198.36 Million |
+4.21% |
| 2016-12-31 | MX$3.31 Billion ≈ $190.35 Million |
+1.97% |
| 2015-12-31 | MX$3.24 Billion ≈ $186.66 Million |
+4.38% |
| 2014-12-31 | MX$3.11 Billion ≈ $178.84 Million |
+12.68% |
| 2013-12-31 | MX$2.76 Billion ≈ $158.70 Million |
+6.56% |
| 2012-12-31 | MX$2.59 Billion ≈ $148.93 Million |
+19.10% |
| 2011-12-31 | MX$2.17 Billion ≈ $125.05 Million |
+15.63% |
| 2010-12-31 | MX$1.88 Billion ≈ $108.15 Million |
+9.52% |
| 2009-12-31 | MX$1.72 Billion ≈ $98.75 Million |
+11.27% |
| 2008-12-31 | MX$1.54 Billion ≈ $88.75 Million |
+9.19% |
| 2007-12-31 | MX$1.41 Billion ≈ $81.28 Million |
+16.48% |
| 2006-12-31 | MX$1.21 Billion ≈ $69.78 Million |
+17.79% |
| 2005-12-31 | MX$1.03 Billion ≈ $59.24 Million |
+14.27% |
| 2004-12-31 | MX$900.86 Million ≈ $51.84 Million |
+16.62% |
| 2003-12-31 | MX$772.45 Million ≈ $44.45 Million |
+17.09% |
| 2002-12-31 | MX$659.71 Million ≈ $37.97 Million |
+20.84% |
| 2001-12-31 | MX$545.95 Million ≈ $31.42 Million |
+10.81% |
| 2000-12-31 | MX$492.70 Million ≈ $28.36 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Médica Sur S.A.B. de C.V's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 6629.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | MX$1.96 Billion | 77.91% |
| Other Components | MX$556.97 Million | 22.09% |
| Total Equity | MX$2.52 Billion | 100.00% |
Médica Sur S.A.B. de C.V Competitors by Market Cap
The table below lists competitors of Médica Sur S.A.B. de C.V ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Qingyan Environmental Technology Co. Ltd.
SHE:301288
|
$313.26 Million |
|
Tjk Machinery Tianjin Co Ltd
SHE:300823
|
$313.38 Million |
|
Mesabi Trust
NYSE:MSB
|
$313.44 Million |
|
BH Co Ltd
KQ:090460
|
$313.51 Million |
|
Fujian Cement Inc
SHG:600802
|
$313.15 Million |
|
Deceuninck
BR:DECB
|
$313.07 Million |
|
Hubei Forbon Technology Co Ltd
SHE:300387
|
$313.01 Million |
|
Myoung Shin Industrial Co Ltd
KO:009900
|
$312.91 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Médica Sur S.A.B. de C.V's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,343,039,000 to 2,521,726,000, a change of 178,687,000 (7.6%).
- Net income of 540,249,000 contributed positively to equity growth.
- Dividend payments of 147,024,000 reduced retained earnings.
- Share repurchases of 217,074,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | MX$540.25 Million | +21.42% |
| Dividends Paid | MX$147.02 Million | -5.83% |
| Share Repurchases | MX$217.07 Million | -8.61% |
| Other Changes | MX$2.54 Million | +0.1% |
| Total Change | MX$- | 7.63% |
Book Value vs Market Value Analysis
This analysis compares Médica Sur S.A.B. de C.V's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.16x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | MX$27.95 | MX$59.60 | x |
| 2018-12-31 | MX$28.72 | MX$59.60 | x |
| 2019-12-31 | MX$29.87 | MX$59.60 | x |
| 2020-12-31 | MX$32.51 | MX$59.60 | x |
| 2021-12-31 | MX$39.85 | MX$59.60 | x |
| 2022-12-31 | MX$23.36 | MX$59.60 | x |
| 2023-12-31 | MX$21.27 | MX$59.60 | x |
| 2024-12-31 | MX$24.47 | MX$59.60 | x |
| 2025-12-31 | MX$27.61 | MX$59.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Médica Sur S.A.B. de C.V utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 21.42%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.28%
- • Asset Turnover: 1.00x
- • Equity Multiplier: 1.89x
- Recent ROE (21.42%) is above the historical average (14.42%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 11.06% | 6.18% | 0.61x | 2.92x | MX$3.68 Million |
| 2001 | 13.36% | 10.57% | 0.70x | 1.81x | MX$18.36 Million |
| 2002 | 15.83% | 13.24% | 0.73x | 1.63x | MX$38.47 Million |
| 2003 | 14.54% | 13.24% | 0.71x | 1.55x | MX$35.08 Million |
| 2004 | 14.64% | 14.02% | 0.68x | 1.54x | MX$41.75 Million |
| 2005 | 14.04% | 13.66% | 0.68x | 1.51x | MX$41.53 Million |
| 2006 | 16.02% | 15.86% | 0.72x | 1.40x | MX$72.97 Million |
| 2007 | 15.32% | 15.63% | 0.70x | 1.41x | MX$75.07 Million |
| 2008 | 12.56% | 12.55% | 0.63x | 1.58x | MX$39.49 Million |
| 2009 | 13.80% | 13.37% | 0.63x | 1.64x | MX$65.21 Million |
| 2010 | 12.31% | 12.82% | 0.64x | 1.49x | MX$43.39 Million |
| 2011 | 10.31% | 11.79% | 0.63x | 1.39x | MX$6.79 Million |
| 2012 | 11.61% | 14.38% | 0.62x | 1.30x | MX$41.78 Million |
| 2013 | 13.77% | 16.83% | 0.68x | 1.21x | MX$104.05 Million |
| 2014 | 11.24% | 15.23% | 0.63x | 1.17x | MX$38.40 Million |
| 2015 | 7.43% | 10.58% | 0.60x | 1.16x | MX$-83.26 Million |
| 2016 | 4.32% | 5.51% | 0.47x | 1.65x | MX$-187.69 Million |
| 2017 | 6.73% | 6.76% | 0.61x | 1.63x | MX$-112.79 Million |
| 2018 | 4.78% | 4.69% | 0.66x | 1.54x | MX$-184.78 Million |
| 2019 | 3.82% | 3.80% | 0.63x | 1.59x | MX$-227.60 Million |
| 2020 | 13.94% | 12.51% | 0.71x | 1.57x | MX$158.04 Million |
| 2021 | 23.50% | 29.56% | 0.56x | 1.42x | MX$663.18 Million |
| 2022 | 37.67% | 24.56% | 0.85x | 1.82x | MX$697.67 Million |
| 2023 | 31.18% | 15.38% | 1.00x | 2.03x | MX$431.36 Million |
| 2024 | 19.70% | 10.48% | 1.00x | 1.88x | MX$227.21 Million |
| 2025 | 21.42% | 11.28% | 1.00x | 1.89x | MX$288.08 Million |
Industry Comparison
This section compares Médica Sur S.A.B. de C.V's net assets metrics with peer companies in the Medical Care Facilities industry.
No peer company data available for comparison.
About Médica Sur S.A.B. de C.V
Médica Sur, S.A.B. de C.V. operates as a healthcare hospital in Mexico. The company offers angiology, vascular, and endovascular surgery; bariatric surgery; cancer; cardiology; checkup and preventive medicine; children; dental; emergency; endocrinology; gastroenterology, hepatology, and endoscopy; general surgery; geriatric; and gynecology and obstetrics services. It also provides specialized sur… Read more